ZinBio’s incubator program is suitable for early-stage biotech companies. Early-stage companies have the opportunity to leverage ZinBio’s expertise in the Chinese Cell therapy industry to push Cell therapy pipelines toward the clinical phase in the China market. ZinBio has a variety of different partnership methods including an Equity-for-service model to help super-charge timelines to market.